Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experience

Journal:

Journal of the National Cancer Institute

Published:

2025-12-04

DOI:

10.1093/jnci/djaf343

Affiliations:

19

Authors:

23

Go to article

Institutions	Authors	Share
University of California, San Francisco (UCSF), United States of America (USA)	3.000000	0.13
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)	3.000000	0.13
The University of Texas MD Anderson Cancer Center, United States of America (USA)	2.000000	0.09
The Winship Cancer Institute of Emory University, United States of America (USA)	2.000000	0.09
H. Lee Moffitt Cancer Center & Research Institute, United States of America (USA)	2.000000	0.09
Stanford University, United States of America (USA)	2.000000	0.09
University of Southern California (USC), United States of America (USA)	1.000000	0.04
Medical College of Wisconsin (MCW), United States of America (USA)	1.000000	0.04
Vanderbilt University Medical Center (VUMC), United States of America (USA)	1.000000	0.04
University of Wisconsin-Madison (UW-Madison), United States of America (USA)	1.000000	0.04
The University of Oklahoma (OU), United States of America (USA)	1.000000	0.04
Kaiser Permanente San Francisco Medical Center, United States of America (USA)	1.000000	0.04
Princess Alexandra Hospital, Australia	1.000000	0.04
University of California, San Diego (UC San Diego), United States of America (USA)	1.000000	0.04
University of Cincinnati (UC), United States of America (USA)	1.000000	0.04

Interested in Oncology and Carcinogenesis?